Eli Lilly signs Cognizant deal

Pharmaceutical company Eli Lilly has signed a multiyear deal with Cognizant to provide a range of business services.

Cognizant will deliver commercial analytics, sales force planning, sales incentive compensation, customer relationship management, business reporting, data warehousing and state compliance reporting using a consumption-based service delivery model called business process as a service (BPaaS).

As part of the BPaaS model, Cognizant will combine cloud-based IT infrastructure, proprietary software applications and other intellectual property for commercial operations in life sciences.

"This expansion of our relationship with Cognizant is another step in our mission to become the most customer-focused pharmaceutical company in the US market," said David Ricks, president of Lilly USA.